63
Participants
Start Date
January 31, 2017
Primary Completion Date
February 28, 2018
Study Completion Date
June 30, 2018
A-dmDT390-bisFv(UCHT1)
anti-T cell immunotoxin (antibody targeting CD3 on T-cells tagged with diphtheria toxin without binding domain)
Pembrolizumab
A humanized monoclonal immunoglobulin (Ig) G4 antibody directed against human cell surface receptor PD-1 (programmed death-1 or programmed cell death-1) with potential immune checkpoint inhibitory and antineoplastic activities.
Ionizing Radiation
Electromagnetic or corpuscular radiation capable of producing ions, directly or indirectly, in its passage through matter.
James Graham Brown Cancer Center, Louisville
Lead Sponsor
James Graham Brown Cancer Center
OTHER
Angimmune LLC
INDUSTRY